0.09 ? 0.0 (0.00%)
Volume: 200 @- ET
Bid Ask Day's Range
0.085 0.105 - - -
TSX:ALT Detailed Quote Wiki
Recent ALT News
- Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions • GlobeNewswire Inc. • 06/13/2025 11:30:00 AM
- Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD) • GlobeNewswire Inc. • 05/19/2025 11:30:00 AM
- Altimmune to Participate at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/14/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:55:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:04:35 AM
- Altimmune Announces First Quarter 2025 Financial Results and Business Update • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
- Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™ • GlobeNewswire Inc. • 05/08/2025 11:30:00 AM
- Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 • GlobeNewswire Inc. • 05/06/2025 11:30:00 AM
- Altimmune to Present at Upcoming EASL International Liver Congress™ 2025 • GlobeNewswire Inc. • 05/01/2025 11:30:00 AM
- Altimmune to Participate in the Citizens Life Sciences Conference • GlobeNewswire Inc. • 04/30/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 08:15:22 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/14/2025 04:15:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2025 08:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2025 08:05:11 PM
- Altimmune to Host Virtual R&D Day on March 13, 2025 • GlobeNewswire Inc. • 03/06/2025 12:30:00 PM
- Altimmune to Participate in the Leerink Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2025 12:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/27/2025 09:49:48 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2025 09:36:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2025 12:05:35 PM
- Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 02/27/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:47:43 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:46:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 10:46:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 10:44:25 PM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM